A multicenter study of viral hepatitis in a United States hemophilic population
Authors:
Open Access
- 15 January 1993
- journal article
- Published by American Society of Hematology in Blood
- Vol. 81 (2) , 412-418
Abstract
Hemophilia A and B patients seen at nine US regional treatment centers were tested for serologic markers of hepatitis B virus (HBV), hepatitis C virus (HCV), and hepatitis delta virus (HDV) during 1987 and 1988. Because human immunodeficiency virus (HIV) infection, a potentially confounding variable, was present in 53% of the group, the population was divided by HIV status for analysis purposes. In the HIV-positive group (N = 382), less than 1% had not been infected with HBV, HCV, or HDV, whereas 75% had evidence of infection with HBV and 98% with HCV. HBsAg, a marker of active HBV infection, was present in 12% of subjects; 96% of these were HCV positive. Anti-HDV was detected in 35 subjects (9.1%); all were anti-HBc positive. Ten of the 35 (29%) also were positive for IgM anti-HDV, indicating current infection. All 10 were HBsAg positive and 7 of the 9 tested were HDV RNA positive. Severe/moderate hemophilia B patients were more likely to have experienced an HBV infection and to be anti-HDV positive than were similar hemophilia A patients (22% v 8%, P < .05). In the HIV-negative group (N = 345), the subjects were younger and had less severe hemophilia than the HIV-positive patients. No evidence of HBV, HCV, or HDV infection was found in 18%, whereas 33% had experienced HBV infection and 79% were anti-HCV positive. Within this group, 4% were HBsAg positive. All 13 subjects with anti-HDV (4% of the HIV-negative group) also possessed anti-HBc. One (7.7%) was IgM anti-HDV positive and the serum from another contained HDV RNA. Both of these individuals were HBsAg positive. As in the HIV-positive group, severe/moderate hemophilia B patients were more likely to be HBV and HDV positive than were hemophilia A patients (9% v 3%, P < .05). A prevalence study of viral hepatitis in a large US hemophilic population showed that active infection with HCV is common, occurring in 89% of all study patients regardless of HIV status. Evidence of active HBV infection was found in 8%; 19% of these were actively infected with HDV. HDV was more common in hemophilia B patients after controlling for disease severity.Keywords
This publication has 14 references indexed in Scilit:
- Hepatitis C antibody and chronic liver disease in haemophiliaThe Lancet, 1990
- Infection with hepatitis delta and human immunodeficiency viruses among hemophiliacs in JapanTransfusion, 1988
- Altered natural history of hepatitis B in homosexual males–-a reflection of altered immune responsiveness?Journal of Medical Virology, 1985
- Epidemiology and Clinical Impact of Hepatitis D Virus (Delta) InfectionHepatology, 1985
- INFLUENCE OF DELTA INFECTION ON SEVERITY OF HEPATITIS BThe Lancet, 1982
- Radioimmunoassay detection of igm antibodies to the hbv‐associated delta (δ) antigen: Clinical significance in δ infectionJournal of Medical Virology, 1982
- The high risk of chronic liver disease in multitransfused juvenile hemophiliac patientsThe Journal of Pediatrics, 1979
- Commercial factor VIII associated hepatitis, 1974–75, in the United Kingdom: a retrospective surveyEpidemiology and Infection, 1978
- Jaundice and Hepatitis B Surface Antigen and Antibody in Greek HaemophiliacsScandinavian Journal of Haematology, 1977
- The Prevalence of Hepatitis‐B Antigen (HBsAg) and Its Antibody (ANTI‐HBs) Among London Hemophiliacs and Blood Donors from London and Two Tropical AreasTransfusion, 1976